A detailed history of Nu Wave Investment Management, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Nu Wave Investment Management, LLC holds 761 shares of BMRN stock, worth $53,711. This represents 0.07% of its overall portfolio holdings.

Number of Shares
761
Holding current value
$53,711
% of portfolio
0.07%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 21, 2022

BUY
$82.16 - $96.94 $62,523 - $73,771
761 New
761 $65,000
Q2 2022

Jul 08, 2022

SELL
$71.48 - $86.85 $106,362 - $129,232
-1,488 Closed
0 $0
Q1 2022

Apr 12, 2022

BUY
$74.28 - $92.69 $46,647 - $58,209
628 Added 73.02%
1,488 $115,000
Q4 2021

Jan 18, 2022

BUY
$71.72 - $91.47 $61,679 - $78,664
860 New
860 $76,000
Q3 2021

Oct 18, 2021

SELL
$74.77 - $85.47 $188,943 - $215,982
-2,527 Closed
0 $0
Q2 2021

Jul 16, 2021

BUY
$75.51 - $84.79 $6,267 - $7,037
83 Added 3.4%
2,527 $211,000
Q1 2021

Apr 09, 2021

BUY
$74.73 - $90.69 $154,541 - $187,546
2,068 Added 550.0%
2,444 $185,000
Q4 2020

Jan 11, 2021

SELL
$72.61 - $90.2 $318,031 - $395,076
-4,380 Reduced 92.09%
376 $33,000
Q3 2020

Oct 23, 2020

BUY
$71.87 - $131.03 $339,801 - $619,509
4,728 Added 16885.71%
4,756 $361,000
Q2 2020

Jul 13, 2020

BUY
$79.55 - $124.22 $2,227 - $3,478
28 New
28 $3,000
Q1 2020

Apr 14, 2020

SELL
$71.37 - $96.85 $4,496 - $6,101
-63 Closed
0 $0
Q4 2019

Jan 31, 2020

SELL
$64.27 - $86.37 $184,647 - $248,141
-2,873 Reduced 97.85%
63 $5,000
Q3 2019

Oct 15, 2019

BUY
$67.4 - $85.11 $185,350 - $234,052
2,750 Added 1478.49%
2,936 $198,000
Q2 2019

Jul 18, 2019

SELL
$80.35 - $93.9 $281,225 - $328,650
-3,500 Reduced 94.95%
186 $16,000
Q1 2019

Apr 11, 2019

BUY
$84.2 - $98.62 $302,362 - $354,144
3,591 Added 3780.0%
3,686 $327,000
Q4 2018

Jan 22, 2019

SELL
$80.14 - $106.07 $130,467 - $172,681
-1,628 Reduced 94.49%
95 $8,000
Q3 2018

Oct 23, 2018

BUY
$93.92 - $105.72 $161,448 - $181,732
1,719 Added 42975.0%
1,723 $167,000
Q2 2018

Aug 01, 2018

BUY
$76.01 - $99.03 $304 - $396
4 New
4 $0
Q1 2018

May 02, 2018

SELL
$77.67 - $92.63 $1,009 - $1,204
-13 Closed
0 $0
Q4 2017

Feb 07, 2018

BUY
$80.76 - $95.13 $1,049 - $1,236
13
13 $1,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Nu Wave Investment Management, LLC Portfolio

Follow Nu Wave Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nu Wave Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nu Wave Investment Management, LLC with notifications on news.